Article Listing - Pfizer says Torisel combo fails in Ph III for kidney cancer

CHOLESTECH'S HARVEY SADOW

4 May 1992

Harvey Sadow has been elected chairman of the board of Cholestech Corporation. Until he retired in 1988, he was the...

US TAMOXIFEN TRIAL

4 May 1992

The US National Cancer Institute has given the go-ahead for a five-year, placebo-controlled trial of tamoxifen in 16,000 women. It...

LIPOSOME TECHNOLOGY'S MELISSA YEAGER

4 May 1992

Liposome Technology has appointed Melissa Yeager to the position of associate director for regulatory affairs.

PHASE II INTERIM RESULTS OF TLC D-99

4 May 1992

The Liposome Company reports that a high response rate and a good safety profile have been observed with its TLC...

GOOD 1st QTRs for ALZA, IMMUNEX AND MYLAN

4 May 1992

Alza Corp, Immunex and Mylan Laboratories are the three best performers among the US pharmaceutical companies that have announ-ced quarterly...

SCEPTICISM ABOUT CELECTOL BENEFITS

4 May 1992

Claims by Rhone Poulenc Rorer that its new cardioselective beta blocker Celectol (celiprolol) "improves the overall cardiovascular risk profile" in...

FORTHCOMING MEETINGS

4 May 1992

Among the forthcoming meetings and conferences of interest to the industry are:

- International Harmonization: The Outcome of ICH1 and the...

US COURT OVERTURNS NOLVADEX PATENT

4 May 1992

The US Southern District Court of New York has invalidated Imperial Chemical Industries' US patent for its breast cancer treatment...

"INADEQUACY' OF GATT PATENT REGS

4 May 1992

The present round of negotiations at the General Agreement on Trade and Tariffs, even if they are successful, will bring...

KENYA LOOKS TO INDIAN DRUGS

4 May 1992

The government of Kenya says it is hoping to import Indian pharmaceuticals at "competitive prices," which would save it up...